carbostyril has been researched along with Hemorrhagic Fever, Ebola in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, F; Ding, Q; Gan, T; Gao, H; Gong, M; Huang, W; Huang, Y; Li, Q; Nie, J; Rao, Y; Wang, Y; Wu, Y; Yang, Y; Zhang, R; Zhong, J | 1 |
| Bates, P; Diamond, SL; Greenbaum, DC; Huryn, DM; Jing, H; Kaletsky, RL; Myers, MC; Purvis, JE; Shah, PP; Smith, AB; Wang, T | 1 |
2 other study(ies) available for carbostyril and Hemorrhagic Fever, Ebola
| Article | Year |
|---|---|
Novel quinolone derivatives targeting human dihydroorotate dehydrogenase suppress Ebola virus infection in vitro.
Topics: Adenosine Monophosphate; Africa, Western; Alanine; Antiviral Agents; Cell Line; Dihydroorotate Dehydrogenase; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Inhibitory Concentration 50; Quinolones; Virus Replication | 2021 |
A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells.
Topics: Antiviral Agents; Cathepsin L; Cell Line; Cysteine Proteinase Inhibitors; Hemorrhagic Fever, Ebola; Humans; Kinetics; Quinolines; Quinolones; Severe Acute Respiratory Syndrome | 2010 |